Rovalpituzumab tesirine - CAS 1613313-09-9

Rovalpituzumab tesirine (SC-002) is an antibody-drug conjugate (ADC) with anticancer properties. It consists of the DLL3-targeting antibody, Rovalpituzumab, which is linked to a cytotoxic pyrrolobenzodiazepine compound via a protease-cleavable linker. Rovalpituzumab tesirine is utilized in research concerning small cell lung cancer (SCLC) .

Antibody-Drug Conjugates (ADCs), Gamma-secretase

Antibody-drug Conjugate/ADC Related, Stem Cells, Neuroscience, Proteases/Proteasome

1613313-09-9

-20°C

Ice Packs

Inhibitory Antibodies